TABLE 4.
Results of univariate and multivariate Cox regression.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| Race | 0.787 (0.305–2.03) | 0.62 | ||
| Age | 0.998 (0.945–1.053) | 0.931 | ||
| Pathological N | 1.366 (0.643–2.903) | 0.417 | ||
| Pathological T | 4.279 (1.364–13.426) | 0.013 | 1.113 (0.308–4.018) | 0.87 |
| Gleason grade | 2.143 (1.42–3.235) | <0.001 | 1.792 (1.129–2.844) | 0.013 |
| Prior malignancy | 0.767 (0.104–5.638) | 0.794 | ||
| Diagnostic CT or MRI | 1.38 (0.954–1.996) | 0.087 | ||
| Residual tumor | 1.272 (0.897–1.806) | 0.177 | ||
| PSA | 1.012 (0.991–1.034) | 0.255 | ||
| Risk score | 3.423 (1.862–6.293) | <0.001 | 2.099 (1.043–4.224) | 0.038 |
PSA, prostate-specific antigen; and p < 0.05 is defined as statistically significant.